Publisher Correction: The current state and future directions of RNAi-based therapeutics

Ryan L Setten; John J Rossi; Si-Ping Han

doi:10.1038/s41573-019-0023-6

Publisher Correction: The current state and future directions of RNAi-based therapeutics

Nat Rev Drug Discov. 2020 Apr;19(4):291. doi: 10.1038/s41573-019-0023-6.

Authors

Ryan L Setten^{1

2}, John J Rossi^{1

2}, Si-Ping Han^{3

4}

Affiliations

¹ Department of Molecular and Cellular Biology, Beckman Research Institute, City of Hope, Duarte, CA, USA.
² Irell and Manella Graduate School of Biological Sciences, City of Hope, Duarte, CA, USA.
³ Department of Molecular and Cellular Biology, Beckman Research Institute, City of Hope, Duarte, CA, USA. [email protected].
⁴ Materials and Process Simulation Center, California Institute of Technology, Pasadena, CA, USA. [email protected].

PMID: 30886427
DOI: 10.1038/s41573-019-0023-6

Abstract

The use of the names for patisiran has been made consistent throughout the article in line with the journal style and typographical errors have been corrected.

Publication types

Published Erratum

Grants and funding

R01 AI042552/AI/NIAID NIH HHS/United States